Free Trial
OTCMKTS:MATN

Mateon Therapeutics (MATN) Stock Price, News & Analysis

Mateon Therapeutics logo
$0.05 +0.00 (+6.86%)
As of 07/11/2025

About Mateon Therapeutics Stock (OTCMKTS:MATN)

Key Stats

Today's Range
$0.04
$0.05
50-Day Range
$0.04
$0.07
52-Week Range
$0.13
$0.38
Volume
815,380 shs
Average Volume
338,444 shs
Market Capitalization
$4.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MATN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mateon Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MATN Stock News Headlines

Viking Therapeutics Inc.
See More Headlines

MATN Stock Analysis - Frequently Asked Questions

Mateon Therapeutics' stock was trading at $0.0350 at the beginning of 2025. Since then, MATN shares have increased by 55.7% and is now trading at $0.0545.

Mateon Therapeutics, Inc. (OTCMKTS:MATN) announced its quarterly earnings results on Wednesday, May, 15th. The biopharmaceutical company reported ($0.02) EPS for the quarter, meeting analysts' consensus estimates of ($0.02).

Shares of MATN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mateon Therapeutics investors own include Amarin (AMRN), Cyclacel Pharmaceuticals (CYCC), Catalyst Pharmaceuticals (CPRX), Oramed Pharmaceuticals (ORMP), Exelixis (EXEL), Synergy Pharmaceuticals (SGYP) and BioLineRx (BLRX).

Company Calendar

Last Earnings
5/15/2019
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MATN
Previous Symbol
NASDAQ:MATN
CIK
908259
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.64 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-64.66%
Return on Assets
-42.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.17
Quick Ratio
0.17

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.20 per share
Price / Book
0.27

Miscellaneous

Outstanding Shares
90,240,000
Free Float
N/A
Market Cap
$4.92 million
Optionable
Not Optionable
Beta
1.33

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:MATN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners